Browse hierarchy: [Radiology (RA)](/submissions/RA) → [Subpart F — Therapeutic Devices](/submissions/RA/subpart-f%E2%80%94therapeutic-devices) → [21 CFR 892.5735](/submissions/RA/subpart-f%E2%80%94therapeutic-devices/892.5735) → QXR — Vaginal Hydrogel Packing System

# QXR · Vaginal Hydrogel Packing System

_Radiology · 21 CFR 892.5735 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/QXR

## Overview

- **Product Code:** QXR
- **Device Name:** Vaginal Hydrogel Packing System
- **Regulation:** [21 CFR 892.5735](/submissions/RA/subpart-f%E2%80%94therapeutic-devices/892.5735)
- **Device Class:** 2
- **Review Panel:** [Radiology](/submissions/RA)

## Identification

A vaginal hydrogel packing system is a nonpowered positioning device composed of a flexible container filled with a hydrogel. The device is intended to reduce the radiation dose delivered to adjacent pelvic organs by temporarily displacing the vaginal wall and adjacent pelvic tissues during radiation therapy planning and delivery, and to stabilize radiation treatment equipment during radiation therapy planning and delivery.

## Classification Rationale

Class II (special controls). The device is granted under De Novo classification (21 CFR 892.5735) as the probable benefits outweigh the probable risks, and the risks can be mitigated by the use of general controls and the identified special controls.

## Special Controls

In combination with the general controls of the FD&C Act, the vaginal hydrogel packing system is subject to the following special controls:

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN220052](https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/QXR/DEN220052.md) | BrachyGel Vaginal Hydrogel Packing System | Brachyfoam, Inc. D/B/A Advaray | Aug 22, 2023 | DENG |

## Top Applicants

- Brachyfoam, Inc. D/B/A Advaray — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/QXR](https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/QXR)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com